Biotech entity
Every one of those 1 sits in a single category, pharma. Todd James is most often covered alongside Bambusa Therapeutics, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.6 for the broader beat in this window.
Last mentioned: Mar 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Todd James is most often covered alongside Bambusa Therapeutics, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.6 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 6 for that window. Todd James appears in 1 tracked Biotech story from March 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Todd James. Shared-story counts are live from our verified record — not editorial picks.
Bambusa Therapeutics has appointed Todd James, a biopharmaceutical executive with over two decades of experience, as its new Chief Financial Officer. The move signals a strategic focus on capital markets and investor relations as the company prepares for its next phase of growth.
Source: digitalmore.co · manilatimes.net
Todd James is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
